8
WORLD GASTROENTEROLOGY NEWS APRIL 2018
Editorial | Expert Point of View | WCOG at ACG 2017 | WDHD News | WGO & WGOF News | WGO Global Guidelines | Calendar of Events
7. Van Rheenen PF, Van de Vijver
E, Fidler V. Faecal calprotectin for
screening of patients with suspected
inflammatory bowel disease:
diagnostic meta-analysis. BMJ.
2010;341:c3369.
8. Asser L, Nanton S, Price T, Holt
H, Johnson M. PTH-069 Is a false
positive faecal calprotectin as false
as you think? : BMJ Publishing
Group; 2017.
9. Carroccio A, Iacono G, Cottone
M, Di Prima L, Cartabellotta F,
Cavataio F, et al. Diagnostic accuracy
of fecal calprotectin assay
in distinguishing organic causes
of chronic diarrhea from irritable
bowel syndrome: a prospective
study in adults and children. Clin
Chem. 2003;49(6):861-7.
10. Mindemark M, Larsson A.
Ruling out IBD: estimation of
the possible economic effects of
pre-endoscopic screening with
F-calprotectin. Clin Biochem.
2012;45(7):552-5.
11. Soubieres A, Boa F, Davie S, Kent
L, Uddin F, Poullis A. PTU-062
Endoscopy workload following
the introduction of faecal calprotectin
(FCP)–does fcp testing
reduce lower gi endoscopies?–part
of a nice nhs adoption site study
in wandsworth. BMJ Publishing
Group; 2015.
12. Schoepfer AM, Beglinger C,
Straumann A, Trummler M,
Vavricka SR, Bruegger LE, et al.
Fecal calprotectin correlates more
closely with the Simple Endoscopic
Score for Crohn’s disease
(SES-CD) than CRP, blood
leukocytes, and the CDAI. The
American journal of gastroenterology.
2010;105(1):162-9.
13. Mooiweer E, Severs M, Schipper
ME, Fidder HH, Siersema PD,
Laheij RJ, et al. Low fecal calprotectin
predicts sustained clinical
remission in inflammatory bowel
disease patients: a plea for deep
remission. Journal of Crohn’s and
Colitis. 2014;9(1):50-5.
14. Rosenfeld G, Greenup A-J, Round
A, Takach O, Halparin L, Saadeddin
A, et al. FOCUS: Future of
fecal calprotectin utility study
in inflammatory bowel disease.
World journal of gastroenterology.
2016;22(36):8211.
15. Wright EK, Kamm MA, De
Cruz P, Hamilton AL, Ritchie
KJ, Krejany EO, et al. Measurement
of fecal calprotectin improves
monitoring and detection
of recurrence of Crohn’s disease
after surgery. Gastroenterology.
2015;148(5):938-47. e1.